Results 151 to 160 of about 169,791 (171)

Left ventricular assist devices [PDF]

Heart, 2009
Left ventricular assist device (LVAD) insertion in patients with advanced heart failure with deteriorating clinical status is life saving, and LVADs are now being inserted into an increasing number of patients with advanced heart failure. They were initially inserted as a bridge to transplantation, and the decreased availability of donor hearts means ...
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Understanding Left Ventricular Assist Devices

Blood Purification, 2018
<b><i>Background/Aims:</i></b> Long-term mechanical assist devices are now commonly used in the treatment of severe heart failure to unload the failing ventricle, maintain sufficient end-organ perfusion and improve functional capacity.
Aissaoui, Nadia (Dr. rer. nat.), Jouan, Jerome, Gourjault, Melissa, Diebold, Benoit (Prof. Dr.), Ortuno, Sofia, Hamdan, Amer, Latremouille, Christian (Prof. Dr. med.), Pirracchio, Romain (Prof. Dr. med.), Morshuis, Michiel (Dr. med.)   +8 more
openaire   +4 more sources

Left Ventricular Assist Devices

2016
The therapy regimen of acute and chronic heart failure consists of medical therapy, causal cardiac surgery and, as ultima ratio, heart transplantation or mechanical circulatory support (MCS). MCS comprises diverse technologies for short- and long-term hemodynamic support.
Renate B. Schnabel, Alexander M. Bernhardt, Christina Baum   +2 more
openaire   +4 more sources

CT of Left Ventricular Assist Devices

RadioGraphics, 2010
Left ventricular assist devices (LVADs) have become an increasingly beneficial option for patients with heart failure, especially in light of the insufficient availability of donor hearts. LVADs have been used effectively in end-stage heart failure as a bridge to heart transplantation, as destination therapy for those ineligible for transplantation, or
Carrie M. Carr, Eric E. Williamson, Barry L. Karon, Jaisy Jacob, Philip A. Araoz, Soon J. Park   +5 more
openaire   +3 more sources

Implantable Left Ventricular Assist Devices

New England Journal of Medicine, 1998
Congestive heart failure affects about 1 percent of adults in the United States1 and is a contributing factor in over 250,000 deaths annually.2 It is diagnosed in 400,000 Americans each year3 and is the primary diagnosis for over 900,000 hospitalizations per year.4 In 1990 the age-adjusted death rate from congestive heart failure was 106.4 per 100,000 ...
Eric A. Rose, Daniel J. Goldstein, Mehmet C. Oz   +2 more
openaire   +3 more sources

Implantation of the Left Ventricular Assist Device

Journal of Cardiac Surgery, 1987
Development of mechanical devices for support of the failing heart is a major goal in cardiac surgery. The application of left ventricular assist device (LVAD) is a promising approach in the case of severe and otherwise untreatable cardiac failure.
Walter Klepetko, Ernst Wolner
openaire   +3 more sources

Left Ventricular Assist Device in Pregnancy

Obstetrics & Gynecology, 2011
: Left ventricular assist devices have become increasingly common for the treatment of acute and chronic heart failure. It is unclear whether these devices can handle the increased stresses caused by pregnancy.: An 18-year-old woman received a left ventricular assist device after peripartum cardiomyopathy.
Shane J. LaRue, I.-W. Wang, Diane Anderson, Gregory A. Ewald, Susan M. Joseph, Anthony Shanks   +5 more
openaire   +2 more sources

Left Ventricular Assist Devices

2005
Left ventricular assist devices (LVADs) have become the standard of care for potential heart transplant patients with life-threatening heart failure refractory to medical therapy. Significant advances in both the technology and the clinical experience have taken place.
Paul L. DiGiorgi, Mehmet C. Oz, Yoshifumi Naka   +2 more
openaire   +2 more sources

Immunobiology of left ventricular assist devices

Progress in Cardiovascular Diseases, 2000
The increasing use of implanted biomaterial devices has made it evident that no material is biologically inert. As a result of direct contact with elements of the blood circulation, such as during hemodialysis or after left ventricular assist device (LVAD) implantation, significant changes in systemic immunologic and thrombostatic functions occur.
Alfred A Kocher, Jan-Hendrik Ankersmit, M. Schuster, Silviu Itescu   +3 more
openaire   +3 more sources

An Extravascular Left Ventricular Assist Device

The Annals of Thoracic Surgery, 1976
The hemodynamic efficacy and prosthesis-vessel interaction of a pneumatically activated circulatory assist device was investigated in 12 acute and 12 chronic studies in dogs. A polyurethane balloon encased in Dacron-velour cloth was fastened to the descending thoracic aorta with a spiral wrapping of Dacron graft material.
Gerald Mandell, Charles A. Baechler, Hisamichi Baba, Kantrowitz A, Issei Kiso, Osami Hamada   +5 more
openaire   +3 more sources